Mammalian target of rapamycin inhibitors for heart transplant patients-Reference-Cited by-同舟云学术

Mammalian target of rapamycin inhibitors for heart transplant patients

Published:2016-08-01 Issue: Volume: Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Møller Christian H¹,Gustafsson Finn²,Gluud Christian³,Penninga Luit⁴

Affiliation:

1. Rigshospitalet, Copenhagen University Hospital; Department of Cardiothoracic Surgery; Blegdamsvej 9 Copenhagen Denmark 2100

2. Copenhagen University Hospital; Department of Cardiology B; Blegdamsvej 9 Copenhagen Denmark DK-2100

3. Copenhagen Trial Unit, Centre for Clinical Intervention Research, Department 7812, Rigshospitalet, Copenhagen University Hospital; The Cochrane Hepato-Biliary Group; Blegdamsvej 9 Copenhagen Denmark DK-2100

4. Department 7812, Rigshospitalet, Copenhagen University Hospital; Copenhagen Trial Unit, Centre for Clinical Intervention Research; Blegdamsvej 9 Copenhagen Denmark DK-2100

Publisher

Wiley

Subject

Pharmacology (medical)

Link

https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD011206.pub2/epdf/full

Reference41 articles.

1. Renal protective strategies in heart transplant patients;Cantarovich;Current Opinion in Cardiology,2007

2. Bias in meta-analysis detected by a simple, graphical test;Egger;BMJ,1997

3. Everolimus for the prevention of allograft rejection and vasculopathy in cardiac transplant recipients;Eisen;New England Journal of Medicine,2003

4. Calcineurin inhibitor-sparing regimens in solid organ transplantation: focus on improving renal function and nephrotoxicity;Flechner;Clinical Transplantation,2008

5. Bias in clinical intervention research;Gluud;American Journal of Epidemiology,2006